Skip to content

Clinical trials

Completed Phase 2 Glioblastoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 2 Status: Completed Clear all

295 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
200112
20027
200310
20048
200516
200619
200726
200818
200922
201016
201116
201210
201315
20148
201512
201610
201711
20186
20195
20206
20215
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed295

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)27
Duke University23
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins9
European Organisation for Research and Treatment of Cancer - EORTC8
Dana-Farber Cancer Institute6
M.D. Anderson Cancer Center6
Memorial Sloan Kettering Cancer Center6
Burzynski Research Institute5
Hoffmann-La Roche5
Jonsson Comprehensive Cancer Center5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma295
Brain Neoplasms129
Gliosarcoma129
Glioma92
Central Nervous System Neoplasms71
Astrocytoma69
Oligodendroglioma43
Ependymoma12
Recurrence11
Glioma, Subependymal10

Trials

Showing 1 to 25 of 295. Each trial links to its page on Pharma Observatory.

195 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.